Chronic graft-versus-host disease
ICD-10 D89.811 is a billable code used to indicate a diagnosis of chronic graft-versus-host disease.
Chronic graft-versus-host disease (cGVHD) is a serious complication that can occur after allogeneic hematopoietic stem cell transplantation (HSCT). It arises when donor immune cells attack the recipient's tissues, leading to a range of symptoms that can affect multiple organ systems. Clinically, cGVHD can manifest in the skin, liver, gastrointestinal tract, lungs, and eyes, among other areas. Symptoms may include skin rashes, jaundice, dry eyes, and gastrointestinal disturbances. The condition can develop months to years after transplantation, distinguishing it from acute graft-versus-host disease, which typically occurs within the first 100 days post-transplant. Diagnosis is based on clinical findings, patient history, and sometimes biopsy of affected tissues. Management often involves immunosuppressive therapies to mitigate the immune response, and ongoing monitoring is essential to manage complications and improve quality of life for affected patients.
Detailed clinical notes on the patient's transplant history, symptoms, and treatment plans.
Patients presenting with skin rashes, liver dysfunction, or gastrointestinal symptoms post-transplant.
Close collaboration with transplant teams is essential for accurate coding.
Photographic evidence of skin manifestations and detailed descriptions of lesions.
Patients with skin involvement requiring dermatological intervention.
Documentation must clearly link skin findings to cGVHD.
Used when a patient with cGVHD requires chemotherapy for management.
Document the reason for chemotherapy and the patient's cGVHD status.
Oncology specialists should ensure accurate coding of the treatment plan.
Acute graft-versus-host disease typically occurs within the first 100 days post-transplant and presents with more severe symptoms, while chronic graft-versus-host disease can develop later and often involves a broader range of symptoms affecting multiple organ systems.
